Maynard Um
-
-
-
-
-
-
-
Azitra receives US patent for ATR-12 Netherton syndrome treatment
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Reports Safety Data from Phase 1b Trial in Netherton Syndrome
-
-
-
-
-
-
-
Azitra, Inc. (AZTR) Reports Q3 Loss of $0.17
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents
-
471,260 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


